Klaria announced the formation of Cannabis Delivery Sciences (CDS). The new company is a separate entity operating within the Klaria group and focuses exclusively on the commercialization of cannabis products formulated with Klaria's Alginate Film Technology. The mission of Cannabis Delivery Sciences is to create an entirely new, patent protected category of cannabis products. This new category of will combine the best qualities of the two currently available formulations of cannabis, edibles and smoking, without any of the drawbacks of either formulation. Klaria and Scott de Mercado are co-founders and own 95% and 5% of the company respectively. Cannabis Delivery Sciences is a subsidiary of Klaria Pharma Holding AB (publ), and has secured an exclusive and perpetual world-wide license to Klaria's Alginate Film Technology for both medicinal and recreational use of all cannabinoids, including CBD and THC. The company is led by an international management team with experience from the United States, Canada, Jamaica, and the UK in entrepreneurial companies focused on the marketing of luxury goods and high-end spirits as well as on pharmaceutical development.